Home/ Supplements/ Niacin/ GABA Relaxer

GABA Relaxer

product on market Tablet or Pill Country Life Safety: 94/100
94/100

This product looks safe

  • Niacin: 200mg is 5.7× the Tolerable Upper Intake Level (35mg)
  • 67% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines B vitamins, taurine, inositol, and glycine, which are researched for their roles in neurotransmitter synthesis and nervous system support. There is moderate evidence suggesting these ingredients may promote relaxation and cognitive function. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 200mg is 5.7× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for GABA Relaxer
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
15
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

200 mg (1000% DV)
Exceeds UL by 5.7× (UL: 35 mg) 196 studies (A:5, B:63)
20 mg (1000% DV)
15.4× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
600 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
600 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Glycine
400 mg
GABA
200 mg

Other Ingredients

Cellulose Stearic Acid Cellulose & Glycerin Coating Magnesium Stearate Silica Natural flavor Vegetable Glaze
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults take two (2) tablets before bedtime. Do not exceed recommended dose. As a reminder, discuss the supplements and medications that you take with your health care providers.

Warnings & Precautions

Do not accept if seal is broken.

Keep out of the reach of children.

WARNING: Not for use by pregnant or nursing women.

Do not operate heavy machinery or drive a motor vehicle after taking this supplement.

If you are taking medication or planning a surgery, consult your doctor before using this product.

If any adverse reactions occur, stop taking the product and consult your doctor.

Formulation Notes

with Vitamin B6

Gluten-Free

NO: Yeast, wheat, soy, gluten, milk, salt, preservatives or artificial color.

Additional Information

Product No. 1500 05I11L

Store between 59(0)-86(0) F.

B6 aids in the utilization of amino acids.

This product has been manufactured at an NSF GMP Registered facility.

Certified Vegan AVA(TM) American Vegetarian Association Certified GF(R) Gluten-Free Good Manufacturing Practices GMP CERTIFIED Our manufacturing supports wind power renewablechoice.com PLEASE RECYCLE

K

AMINO ACIDS

Free Form Amino Acid Supplement with Vitamin B6

Rapid Release(R)

Metadata

Product Details

UPC / SKU0 15794 01500 0
DSLD Entry Date2012-10-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID13116
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.